SANDIP PANDA

Dr. SANDIP PANDA


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in World Journal of Nephrology
Verified
Journal Article
Open access
VBVinant Bhargava
Vinant Bhargava
KSKulwant Singh
Kulwant Singh
SPSANDIP PANDA
SANDIP PANDA
RSRupan Sanyal
Rupan Sanyal
Nephrogenic systemic fibrosis: A frivolous entity

1 July 2020 in Current Medicine Research and Practice
Verified
Journal Article
Closed access
SPSANDIP PANDA
SANDIP PANDA
VBVinant Bhargava
Vinant Bhargava
DRDevinder Singh Rana
Devinder Singh Rana
ABAnil Kumar Bhalla
Anil Kumar Bhalla
AGAshwani Gupta
Ashwani Gupta
Starting from December 2019 in China, SARS-CoV-2, a novel coronavirus strain has rapidly spread to involve more than 150 countries. SARS-CoV-2 is not only responsible for causing pneumonia, but there are also concerns regarding the involvement of other organs such as the heart, liver, and kidneys. Here, we review kidney involvement in COVID 19, the mechanism of kidney injury, and its impact on mortality. Lastly, we focus on the challenges of COVID19 in dialysis and renal transplant patients.

27 August 2020 in Kidney360
Verified
Journal Article
Closed access
PDF file
SPSANDIP PANDA
SANDIP PANDA
VBVinant Bhargava
Vinant Bhargava
DRDevinder Rana
Devinder Rana
ABAnil Bhalla
Anil Bhalla
AGAshwani Gupta
Ashwani Gupta
Kidney transplantation is the preferred treatment modality in patients with ESKD. However, there are associated complications that arise from immunosuppressive medications, infections, and associated comorbidities. Neurologic disorders frequently develop in patients who have received a kidney transplant, which in turn increases the associated morbidity and mortality. This review discusses the common neurologic disorders after kidney transplantation, including infections, cognitive decline, drug-related conditions, malignancy, seizure, and other neurologic complications.

21 March 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
SPSANDIP PANDA
SANDIP PANDA
VBVinant Bhargava
Vinant Bhargava
PGPallav Gupta
Pallav Gupta
SPSandip Panda
Sandip Panda
SBSoumyadeep Bhaumik
Soumyadeep Bhaumik
Introduction: Snakebite is a public health problem leading to about 58,000 deaths every year in India. Kidney injury subsequent to snakebite envenomation is common with a reported prevalence of up to 32%. The current study aims to elucidate the spectrum of kidney histopathology in acute kidney injury (AKI) cases associated with snake bites.Methods: We searched seven electronic database studies to identify studies describing the histopathological findings in the kidney with snakebite envenomation. Two reviewers independently conducted titles and abstract screening as well as full-text evaluation for the final inclusion decision. Data were extracted as per the standardized form. We conducted narrative synthesis. Studies done exclusively on autopsy findings, in vitro studies, and case reports were excluded.Results: We retrieved 1464 studies and finally included 28 studies which met the eligibility criteria in the analysis. Most studies were single-centre and the majority were cross-sectional. Overall we included a total of 534 renal biopsies. Russell’s viper bite was the most common cause related to AKI. Acute tubular necrosis was the most common finding followed by acute interstitial nephritis, acute cortical necrosis (ACN), and thrombotic microangiopathy (TMA). Vasculitis changes in vessels were rarely reported. Lesions such as ACN and TMA were associated with poor outcomes.Conclusion: This analysis supports the notion that renal biopsies are important to guide prognosis and increase our knowledge about post-snake bite AKI pathophysiology.

31 January 2025 in Medicine
Verified
Journal Article
Open access
SPSANDIP PANDA
SANDIP PANDA
RGRuju Md Gala
Ruju Md Gala
RDRashmi Ranjan Das
Rashmi Ranjan Das
VBVinant Md Bhargava
Vinant Md Bhargava
YSYellampalli Md Saivani
Yellampalli Md Saivani
KAKrishna Kumar Md Agrawaal
Krishna Kumar Md Agrawaal
Background: Pregnancy-associated atypical hemolytic uremic syndrome (p-aHUS) is a rare, life-threatening condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, elevated liver enzymes, and acute kidney injury. Prompt diagnosis and therapy are crucial due to the high risk of progression to chronic kidney disease (CKD), end-stage kidney disease (ESKD), and dialysis dependency, as well as significant maternal and fetal morbidity and mortality. Methods: A comprehensive literature search was conducted across EMBASE, MEDLINE, and the Cochrane CENTRAL from January 2000 to March 2024. Studies reporting on pregnancy and kidney outcomes in women diagnosed with p-aHUS were included. Results: Ten studies involving 386 pregnancies in 380 patients met the inclusion criteria for the final analysis. Renal outcomes varied, with mean creatinine levels ranging from 0.72 to 8.734 mg/dL. Dialysis was required in 66.6% of patients, and 25% developed ESKD. Maternal complications included preeclampsia (36.4%) and hemolysis, elevated liver enzymes, and low platelets syndrome (29.7%), with a 5% maternal mortality rate. Fetal complications included intrauterine fetal demise (n = 25), intrauterine growth restriction, low birth weight, and prematurity. Treatment with eculizumab significantly reduced the risk of CKD and ESKD, with a pooled risk ratio of 0.20 (95% confidence interval: 0.09–0.44) and low heterogeneity (I² = 0%, P = .43). Conclusion: This analysis highlights the severe kidney and pregnancy outcomes associated with p-aHUS. Eculizumab treatment is significantly beneficial in reducing the risk of CKD and ESKD.

1 October 2021 in The Lancet
Verified
Journal Article
Closed access
SBSoumyadeep Bhaumik
Soumyadeep Bhaumik
MGMaya Gopalakrishnan
Maya Gopalakrishnan
SPSANDIP PANDA
SANDIP PANDA